Invion Tripping The Light To Fantastic Results
Australian biotech Invion Limited has had a busy 2018, and it expects to keep that momentum going in 2019.
Read More
Invion Limited
Australian life-sciences firm Invion is leading the global clinical development of a novel PhotoDynamic Therapy (PDT) for cancer. Invion’s novel photosensitiser (the agent used in PDT) is called IVX-PDT and is based on the PhotosoftTM Technology.
Spotlight Videos
Invion Tripping The Light To Fantastic Results
Australian biotech Invion Limited has had a busy 2018, and it expects to keep that momentum going in 2019.
WATCH VIDEOAll Invion Limited Content
News
